Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods of treating conditions caused by increased expression of nerve growth factor (NGF) or increased sensitivity to NGF using anti-NGF neutralizing antibodies as selective NGF pathway inhibitors

US Patent 9260514 · Granted Feb 16, 2016

Estimated economic value: $528,657,000

Assignee

Inventors

View full patent text on Google Patents →